Cardlytics, Inc. (CDLX)
NASDAQ: CDLX · Real-Time Price · USD
1.340
-0.090 (-6.29%)
Nov 13, 2026, 4:00 PM EST - Market closed
Cardlytics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 175.92 | 233.27 | 278.3 | 309.2 | 298.54 | 267.12 | |
Revenue Growth | -25.28% | -16.18% | -9.99% | 3.57% | 11.77% | 42.93% |
Cost of Revenue | 88.49 | 128.66 | 157.4 | 178.83 | 184.01 | 162.72 |
Gross Profit | 87.43 | 104.61 | 120.89 | 130.38 | 114.53 | 104.4 |
Selling, General & Admin | 69.09 | 86.75 | 109.13 | 116.24 | 151.59 | 131.82 |
Research & Development | 27.95 | 39.77 | 49.61 | 51.35 | 52.84 | 37.8 |
Operating Expenses | 121.44 | 151.75 | 184.43 | 194.05 | 241.97 | 199.49 |
Operating Income | -34 | -47.14 | -63.53 | -63.67 | -127.44 | -95.09 |
Interest Expense | -10.72 | -10.63 | -8.9 | - | -2.56 | -12.56 |
Interest & Investment Income | 1.48 | 2.71 | 3.35 | - | - | - |
Currency Exchange Gain (Loss) | -1.27 | 6.25 | -1.27 | 3.3 | -6.38 | -1.27 |
Other Non Operating Income (Expenses) | - | - | -0 | -2.34 | - | - |
EBT Excluding Unusual Items | -44.52 | -48.81 | -70.36 | -62.7 | -136.37 | -108.92 |
Merger & Restructuring Charges | 0.19 | -0.56 | -0.16 | 6.31 | -5.23 | -25.17 |
Impairment of Goodwill | -0.02 | -49.12 | -117.77 | -70.52 | -396.24 | - |
Gain (Loss) on Sale of Assets | - | 4.83 | - | -6.55 | - | - |
Asset Writedown | 0.02 | -9.72 | -13.82 | - | -57.05 | -0.96 |
Other Unusual Items | - | -0.1 | 12.81 | -1.25 | 128.17 | -1.37 |
Pretax Income | -46.72 | -103.49 | -189.3 | -134.7 | -466.71 | -136.43 |
Income Tax Expense | - | - | - | - | -1.45 | -7.86 |
Net Income | -36.55 | -103.49 | -189.3 | -134.7 | -465.26 | -128.57 |
Net Income to Common | -36.55 | -103.49 | -189.3 | -134.7 | -465.26 | -128.57 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 6 | 5 | 5 | 4 | 3 | 3 |
Shares Outstanding (Diluted) | 6 | 5 | 5 | 4 | 3 | 3 |
Shares Change | 8.01% | 9.83% | 32.54% | 9.18% | 3.78% | 18.33% |
EPS (Basic) | -6.47 | -19.48 | -39.14 | -36.92 | -139.22 | -39.92 |
EPS (Diluted) | -6.47 | -19.48 | -39.14 | -36.92 | -139.22 | -39.92 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.2 | 8.81 | -10.39 | -0.85 | -55.08 | -41.63 |
Free Cash Flow Per Share | -1.27 | 1.66 | -2.15 | -0.23 | -16.48 | -12.93 |
Gross Margin | 49.70% | 44.85% | 43.44% | 42.17% | 38.36% | 39.08% |
Operating Margin | -19.33% | -20.21% | -22.83% | -20.59% | -42.69% | -35.60% |
Profit Margin | -20.78% | -44.36% | -68.02% | -43.56% | -155.84% | -48.13% |
Free Cash Flow Margin | -4.09% | 3.78% | -3.73% | -0.28% | -18.45% | -15.58% |
EBITDA | -9.61 | -21.9 | -37.84 | -37.21 | -89.89 | -65.22 |
EBITDA Margin | -5.46% | -9.39% | -13.60% | -12.03% | -30.11% | -24.42% |
D&A For EBITDA | 24.39 | 25.24 | 25.69 | 26.46 | 37.54 | 29.87 |
EBIT | -34 | -47.14 | -63.53 | -63.67 | -127.44 | -95.09 |
EBIT Margin | -19.33% | -20.21% | -22.83% | -20.59% | -42.69% | -35.60% |